BioNexus Gene Lab Corp. (BGLC)

USD 2.8

(4.87%)

Total Liabilities Summary of BioNexus Gene Lab Corp.

  • BioNexus Gene Lab Corp.'s latest annual total liabilities in 2023 was 1.74 Million USD , down -16.06% from previous year.
  • BioNexus Gene Lab Corp.'s latest quarterly total liabilities in 2024 Q2 was 1.59 Million USD , down -12.29% from previous quarter.
  • BioNexus Gene Lab Corp. reported annual total liabilities of 2.07 Million USD in 2022, down -13.34% from previous year.
  • BioNexus Gene Lab Corp. reported annual total liabilities of 2.39 Million USD in 2021, down -30.65% from previous year.
  • BioNexus Gene Lab Corp. reported quarterly total liabilities of 1.81 Million USD for 2024 Q1, up 4.33% from previous quarter.
  • BioNexus Gene Lab Corp. reported quarterly total liabilities of 1.93 Million USD for 2023 Q2, up 18.74% from previous quarter.

Annual Total Liabilities Chart of BioNexus Gene Lab Corp. (2023 - 2016)

Historical Annual Total Liabilities of BioNexus Gene Lab Corp. (2023 - 2016)

Year Total Liabilities Total Liabilities Growth
2023 1.74 Million USD -16.06%
2022 2.07 Million USD -13.34%
2021 2.39 Million USD -30.65%
2020 3.45 Million USD 3071.74%
2019 108.87 Thousand USD -16.45%
2018 130.31 Thousand USD -88.94%
2017 1.17 Million USD 88026.7%
2016 1337.00 USD 0.0%

Peer Total Liabilities Comparison of BioNexus Gene Lab Corp.

Name Total Liabilities Total Liabilities Difference
Aclaris Therapeutics, Inc. 40.22 Million USD 95.67%
Applied DNA Sciences, Inc. 8.77 Million USD 80.158%
Aspira Women's Health Inc. 8.62 Million USD 79.808%
Biodesix, Inc. 94.51 Million USD 98.157%
bioAffinity Technologies, Inc. 3.36 Million USD 48.253%
bioAffinity Technologies, Inc. 3.36 Million USD 48.253%
Bionano Genomics, Inc. 118.24 Million USD 98.527%
CareDx, Inc 223.28 Million USD 99.22%
Check-Cap Ltd. 1.33 Million USD -30.973%
Castle Biosciences, Inc. 86.54 Million USD 97.987%
DarioHealth Corp. 38.24 Million USD 95.445%
Exact Sciences Corporation 3.32 Billion USD 99.948%
Fulgent Genetics, Inc. 139.82 Million USD 98.754%
Guardant Health, Inc. 1.62 Billion USD 99.893%
ICON Public Limited Company 7.74 Billion USD 99.978%
IDEXX Laboratories, Inc. 1.77 Billion USD 99.902%
Illumina, Inc. 4.36 Billion USD 99.96%
Intelligent Bio Solutions Inc. 5.59 Million USD 68.87%
iSpecimen Inc. 6.07 Million USD 71.341%
Standard BioTools Inc. 159.86 Million USD 98.91%
MDxHealth SA 121.92 Million USD 98.571%
23andMe Holding Co. 206.64 Million USD 99.157%
Medpace Holdings, Inc. 1.09 Billion USD 99.841%
Myriad Genetics, Inc. 312.9 Million USD 99.443%
Mainz Biomed B.V. 12.15 Million USD 85.675%
ENDRA Life Sciences Inc. 1.09 Million USD -59.059%
NeoGenomics, Inc. 739.69 Million USD 99.765%
Neogen Corporation 1.44 Billion USD 99.879%
Inotiv, Inc. 588.04 Million USD 99.704%
Natera, Inc. 691.79 Million USD 99.748%
OpGen, Inc. 13.44 Million USD 87.043%
OPKO Health, Inc. 622.47 Million USD 99.72%
Psychemedics Corporation 6.59 Million USD 73.599%
Prenetics Global Limited 44.01 Million USD 96.042%
Prenetics Global Limited 44.01 Million USD 96.042%
Precipio, Inc. 3.67 Million USD 52.562%
Personalis, Inc. 95.65 Million USD 98.179%
RadNet, Inc. 2.07 Billion USD 99.916%
Sera Prognostics, Inc. 25.28 Million USD 93.11%
Sotera Health Company 2.68 Billion USD 99.935%
Neuronetics, Inc. 81.64 Million USD 97.866%
Star Equity Holdings, Inc. 21.67 Million USD 91.963%
Star Equity Holdings, Inc. 21.67 Million USD 91.963%
Trinity Biotech plc 83.38 Million USD 97.911%
T2 Biosystems, Inc. 62.83 Million USD 97.228%
Twist Bioscience Corporation 152.97 Million USD 98.861%
Exagen Inc. 34.25 Million USD 94.914%